BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25366584)

  • 21. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lesional therapies for in-transit melanoma.
    Nadler A; Look Hong NJ; Alavi N; Abadir W; Wright FC
    J Surg Oncol; 2020 Nov; 122(6):1050-1056. PubMed ID: 32668038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
    Shi VY; Tran K; Patel F; Leventhal J; Konia T; Fung MA; Wilken R; Garcia MS; Fitzmaurice SD; Joo J; Monjazeb AM; Burrall BA; King B; Martinez S; Christensen SD; Maverakis E
    J Am Acad Dermatol; 2015 Oct; 73(4):645-54. PubMed ID: 26259990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.
    Pasquali S; Mocellin S; Mozzillo N; Maurichi A; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M; Rossi CR
    J Clin Oncol; 2014 Mar; 32(9):935-41. PubMed ID: 24516022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma.
    Weide B; Derhovanessian E; Pflugfelder A; Eigentler TK; Radny P; Zelba H; Pföhler C; Pawelec G; Garbe C
    Cancer; 2010 Sep; 116(17):4139-46. PubMed ID: 20564107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model.
    Schmidt H; Bastholt L; Geertsen P; Christensen IJ; Larsen S; Gehl J; von der Maase H
    Br J Cancer; 2005 Aug; 93(3):273-8. PubMed ID: 16052222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in melanoma survival are not related to mitotic rate of the primary tumor.
    Joosse A; van der Ploeg AP; Haydu LE; Nijsten TE; de Vries E; Scolyer RA; Eggermont AM; Coebergh JW; Thompson JF
    Ann Surg Oncol; 2015 May; 22(5):1598-603. PubMed ID: 25408275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in patients with mucosal melanomas.
    Keller DS; Thomay AA; Gaughan J; Olszanski A; Wu H; Berger AC; Farma JM
    J Surg Oncol; 2013 Dec; 108(8):516-20. PubMed ID: 24132665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
    McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
    Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.
    Lau DK; Andrews MC; Turner N; Azad AA; Davis ID; Cebon JS
    Melanoma Res; 2014 Apr; 24(2):144-9. PubMed ID: 24463460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?
    Ribero S; Osella-Abate S; Sanlorenzo M; Balagna E; Senetta R; Fierro MT; Macripò G; Macrì L; Sapino A; Quaglino P
    Ann Surg Oncol; 2015; 22(6):1967-73. PubMed ID: 25388059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated limb infusion for malignant melanoma: predictors of response and outcome.
    Barbour AP; Thomas J; Suffolk J; Beller E; Smithers BM
    Ann Surg Oncol; 2009 Dec; 16(12):3463-72. PubMed ID: 19830498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous interleukin-2 and interferon-alpha therapy associated with cisplatin monochemotherapy in the treatment of metastatic melanoma.
    Andrès P; Cupissol D; Guillot B; Avril MF; Drèno B
    Eur J Dermatol; 1998 Jun; 8(4):235-9. PubMed ID: 9649695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma.
    Safwat A; Schmidt H; Bastholt L; Fode K; Larsen S; Aggerholm N; von der Maase H
    Radiother Oncol; 2005 Nov; 77(2):143-7. PubMed ID: 16216360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry].
    van Zeijl MCT; van den Eertwegh AJM; Wouters MWJM; Jochems A; Schouwenburg MG; Haanen JBAG; Aarts MJ; van den Berkmortel FWPJ; de Groot JWB; Hospers GAP; Kapiteijn E; Koornstra RH; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; van der Hoeven KJM
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel node location in trunk and extremity melanomas: uncommon or multiple lymph drainage does not affect survival.
    Gordon D; Smedby KE; Schultz I; Olsson H; Ingvar C; Hansson J; Gillgren P
    Ann Surg Oncol; 2014 Oct; 21(11):3386-94. PubMed ID: 24866434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A population-based assessment of melanoma: Does treatment in a regional cancer center make a difference?
    Rivard J; Kostaras X; Shea-Budgell M; Chin-Lenn L; Quan ML; McKinnon JG
    J Surg Oncol; 2015 Aug; 112(2):173-8. PubMed ID: 26445222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
    Egger ME; Huber KM; Dunki-Jacobs EM; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM; Callender GG
    J Am Coll Surg; 2013 Jul; 217(1):37-44; discussion 44-5. PubMed ID: 23791271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.